工藤 寿子

Medicine & Life Sciences

1. Hematopoietic Stem Cell Transplantation 100%
2. Langerhans Cell Histiocytosis 69%
3. Child 66%
4. Acute Myeloid Leukemia 64%
5. Japan 62%
6. Pediatrics 58%
7. Aplastic Anaemia 57%
8. Down Syndrome 35%
9. Stem Cell Transplantation 34%
10. Leukemia 32%
11. Acute Promyelocytic Leukemia 27%
12. Human Herpesvirus 6 26%
13. Busulfan 24%
14. Hemophagocytic Lymphohistiocytosis 24%
15. Allogeneic Cells 24%
16. Cytarabine 23%
17. Tissue Donors 23%
18. Precursor Cell Lymphoblastic Leukemia-Lymphoma 23%
19. Melphalan 21%
20. Bone Marrow Transplantation 20%
21. Bone Marrow 20%
22. Unrelated Donors 20%
23. Antilymphocyte Serum 20%
24. Mutation 19%
25. Recurrence 18%
26. Transplantation 18%
27. Immunosuppressive Agents 17%
28. Juvenile Myelomonocytic Leukemia 17%
29. Therapeutics 17%
30. fludarabine 17%
31. Survival 17%
32. Survival Rate 16%
33. Incidence 15%
34. Etoposide 15%
35. Confidence Intervals 15%
36. Whole-Body Irradiation 15%
37. Genes 15%
38. Graft vs Host Disease 15%
39. Human Herpesvirus 4 15%
40. Herpesviridae Infections 15%
41. Progression-Free Survival 14%
42. Transplants 14%
43. Myeloid Leukemia 13%
44. Lymphoma 13%
45. Drug Therapy 13%
46. Leukemia, Megakaryoblastic, Acute 13%
47. Idiopathic Aplastic anemia 13%
48. Hematopoietic Stem Cells 13%
49. Sideroblastic Anemia 11%
50. Diamond-Blackfan Anemia 11%